PSYCHOEMOTIONAL STATE AND QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Abstract
ABSTRACT
Introduction: Systemic lupus erythematosus (SLE) is a disease of uncertain
genesis
characterized by a wide range of clinical manifestations and lesions of various
systems and organs. A number of authors note that the treatment of SLE should focus
not only on improving clinical indicators, but also on the qualitative components of the
patient's well-being, namely, improving the quality of life related to health.
References
LITERATURE
1. Ziyadullaev, S. K., Sultonov, I. I., Dushanova, G. A., & Akbarovna, K. S.
(2021). The Effectiveness Of Pharmacotherapy For Dmards With Ra Depending
On The C3435t Polymorphism Of The Mdr1 Gene. Int. J. of Aquatic
Science, 12(3), 2908-2916.
2. Islomovich, S. I. (2024). GENDER CHARACTERISTICS OF THE CURRENT
RHEUMATOID ARTHRITIS. International journal of medical sciences, 4(10),
3-8.
3. Ilkhom, S. (2023). CAJAM–VOLUME 1. ISSUE 1. 2023. Central Asian
Journal of Advanced Medicine, 1(01), 16-19.
4. Хамраева, Н. А., Султонов, И. И., & Хасанов, Ф. Ш. У. (2019). Кожные
проявления у больных системной красной волчанкой. Вопросы науки и
образования, (28 (77)), 128-131.
5. Тоиров, А. Э., Султонов, И. И., & Тоиров, Э. С. (2020). ЗНАЧЕНИЕ
ДИСФУНКЦИИ ПОЧЕК У БОЛЬНЫХ ОСТРЫМ ИНФАРКТОМ
МИОКАРДА НА ФОНЕ САХАРНОГО ДИАБЕТА 2-ГО ТИПА. Вестник
науки и образования, (9-3 (87)), 86-91.
6. Sultonov, I. I., Kh, Z. S., Ruzybakieva, M. R., Kireev, V. V., Aripova, T. U., &
Suyarov, A. A. (2021). Pharmacogenetic Aspects of Drug Resistance in Rheumatoid Arthritis. Annals of the Romanian Society for Cell Biology, 4147-
4150.
7. Kireev, V. V., Sultonov, I. I., Ziyadulaaev, S. K., Suyarov, A. A., Aripova, T.
U., Usmanbekova, K. T., & Nasretdinova, M. T. (2021). Genetic Engineered
Preparations-An Innovative Approach in the Treatment of Rheumatoid
Arthritis. Annals of the Romanian Society for Cell Biology, 25(3), 4114-4119.
8. Xasanov, F. S., & Sultonov, I. I. (2023). RHEUMATOID ARTHRITIS
TREATED WITH DMARDS AND CARDIOVASCULAR DISEASE
RISK. Oriental Journal of Medicine and Pharmacology, 3(02), 45-52.
9. Нурматова, Л., Султонов, И., & Тоиров, Э. (2011). Эффективность
препаратов пищеварительной активности в комплексном лечении больных
хроническим гепатитом. Журнал проблемы биологии и медицины, (3 (66)),
107-110.
10. Sultonov, I. I., Khamrayev, X. X., & Xasanov, F. SYSTEMIC LUPUS
ERYTHEMATOSUS AND CARDIOVASCULAR PATHOLOGY: WHERE
WE AT?.
11. Sultonov, I. I., Xasanov, F. S., Eshmuratov, S., Uralov, R. S., Shukurova, D., &
Ziyadullayev, S. X. Predictors of Systemic Lupus Erythematosus: A Case-
control Study. International journal of health sciences, 6(S10), 175-182.
12. Djamshedovna, K. D., Alisherovna, K. M., Xudoyberdiyevich, G. X., &
Rustamovich, T. D. (2023). EFFECTIVENESS OF ANTIHYPERTENSIVE
THERAPY IN PREGNANT WOMEN. Spectrum Journal of Innovation,
Reforms and Development, 12, 137-144.
13. Alisherovna, K. M., Erkinovna, K. Z., Djamshedovna, K. D., &
Nizamitdinovich, K. S. (2023). QUALITY OF LIFE PATIENTS WITH
OSTEOARTHRITIS. Journal of new century innovations, 36(1), 164-175.
14. Jamshedovna, K. D., Alisherovna, K. M., Erkinovna, K. Z., & Davranovna, M.
K. (2022). LEFT VENTRICULAR SYSTOLIC DYSFUNCTION IN
PREGNANT WOMEN WITH PRE-ECLAMPSIA WITHOUT
PROTEINURIA. Spectrum Journal of Innovation, Reforms and
Development, 10, 135-140.
15. Djamshedovna, K. D., & Alisherovna, K. M. (2024). CHANGES IN SOME
SYSTEM INDICATORS IN PREGNANT WOMEN WITH
GESTOSIS. Spectrum Journal of Innovation, Reforms and Development, 25,
111-115.
16. Rustamovich, T. D., Alisherovna, K. M., Djamshedovna, K. D., &
Nizamitdinovich, K. S. (2023). Features of the psychoemotional status of
patients with rheumatoid arthritis. Miasto Przyszłości, 32, 23-30.
17. Alisherovna, K. M., & Djamshedovna, K. D. (2024). AFTER COVID-19
QUALITY OF LIFE. Spectrum Journal of Innovation, Reforms and
Development, 25, 103-110.
18. Alisherovna, K. M., Djamshedovna, K. D., Totlibayevich, Y. S., &
Boymamatovna, E. F. (2022). The Effectiveness of the Original Drug
Trimetazidine MV in Patients with Stable Ischemic Heart Disease and Persistent
Angina Attacks Against the Background of the Use of Trimetazidine
Generics. Miasto Przyszłości, 30, 235-238.
19. Rustamovich, T. D., Alisherovna, K. M., Nizamitdinovich, K. S., &
Djamshedovna, K. D. (2022). Gastrointestinal conditions in rheumatoid arthritis
patients. Texas Journal of Medical Science, 15, 68-72.
20. Alisherovna, K. M., Jamshedovna, K. D., Totlibayevich, Y. S., &
Xudoyberdiyevich, G. X. (2022). FEATURES OF THE QUALITY OF LIFE
OF PATIENTS WITH CHRONIC RENAL FAILURE IN THE TREATMENT
OF HEMODIALYSIS. Spectrum Journal of Innovation, Reforms and
Development, 7, 76-81.
21. Khusainova, M. A., Vakhidov, J. J., Khayitov, S. M., & Mamadiyorova, M. M.
(2023). Cardiac arrhythmias in patients with rheumatoid arthritis. Science and
Education, 4(2), 130-137.
22. Khusainova, M. A. (2023). Comorbidity thyrotoxicosis with coronary heart
disease. Science and Education, 4(5), 205-213.
23. Yarmatov, S., Khusainova, M., & Djabbarova, N. (2023). STUDY OF
QUALITY OF LIFE INDICATORS IN PATIENTS WITH CORONARY
HEART DISEASE USING THE SF-36 QUESTIONNAIRE. Бюллетень
студентов нового Узбекистана, 1(7), 58-64.
24. Khusainova, M. A., & Yarmatov, S. T. (2021). CARDIAC ARRHYTHMIAS
AND CARDIOHEMODYNAMIC DISORDERS IN PATIENTS VIRAL
CIRRHOSIS OF THE LIVER. Scientific progress, 2(2), 196-202.
25. Alisherovna, K. M., Ismatullayevich, M. A., & Nuriddinovna, E. N. (2024).
FEATURES OF HEART FAILURE IN PATIENTS WITH CORONARY
HEART DISEASE AND THYROTOXICOSIS. Ta'lim innovatsiyasi va
integratsiyasi, 19(4), 52-61.
26. Alisherovna, K. M., Yaxshiboyevich, U. M. R., & Yigitaliyevich, B. A. (2024).
EVALUATION OF A NATRIURETIC PEPTIDE TO OPTIMIZE THE
MANAGEMENT OF COMORBID PATIENTS WITH THYROTOXICOSIS
AND HEART FAILURE. Ta'lim innovatsiyasi va integratsiyasi, 19(4), 62-70.
27. Alisherovna, K. M., Mansurovna, M. D., Erkinovna, N. D., Farxodovna, X. R.,
Toxirovna, M. M., Tolibovna, R. D., & Yorkinovna, E. N. (2024). ARTERIAL HYPERTENSION AND THYROID STATUS IN PATIENTS OF DIFFERENT
AGES. Ta'lim innovatsiyasi va integratsiyasi, 19(4), 122-129.
28. Alisherovna, K. M., Erkinovna, S. D., Duskobilovich, B. S., & Samandarovich,
T. H. (2024). ARTERIAL HYPERTENSION IN THYROTOXICOSIS AND
REMODELING OF THE LEFT VENTRICLE OF THE HEART. Ta'lim
innovatsiyasi va integratsiyasi, 19(4), 114-121.
29. Alisherovna, K. M., Erkinovna, S. D., Yazdonkulovna, X. M., & Zafarovna, C.
M. M. (2024). ATRIAL FIBRILLATION IN THYROTOXICOSIS–
DETERMINANTS OF DEVELOPMENT AND CONSERVATION. Ta'lim
innovatsiyasi va integratsiyasi, 19(4), 103-113.
30. Alisherovna, K. M., Habibulloyevna, I. M., & Voxidovna, R. F. (2024).
STRUCTURAL AND FUNCTIONAL FEATURES OF THE LEFT
VENTRICLE IN PATIENTS WITH HEART FAILUREIN ISCHEMIC
HEART DISEASE AND THYROTOXICOSIS. Ta'lim innovatsiyasi va
integratsiyasi, 19(4), 71-81.
